Temporomandibular Disorder

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Trauma Exposure and Childhood Trauma in Temporomandibular Joint DisordersN/A1 trial
Active Trials
NCT07292103CompletedEst. Oct 2025

Trial Timeline

Clinical trial activity over time

2025
2026
City TherapeuticsTrauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders

Clinical Trials (1)

NCT07292103City TherapeuticsTrauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders

Trauma Exposure and Childhood Trauma in Temporomandibular Joint Disorders

Start: May 2025Est. completion: Oct 2025
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space